Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Atherosclerosis
|
September 9, 2020
Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experience
Sumayah Aljenedil, Latifah Alothman, Alexandre M Bélanger, et al.
Journal of the Endocrine Society
|
January 30, 2020
Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort
Abhimanyu Garg, Sergio Fazio, P Barton Duell, et al.
The New England Journal of Medicine
|
September 3, 2024
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
Gerald F Watts, Robert S Rosenson, Robert A Hegele, et al.
The Journal of Biological Chemistry
|
December 22, 2016
The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIA
Delia Susan-Resiga, Emmanuelle Girard, Robert Scott Kiss, et al.
Clinical Genetics
|
July 5, 2022
Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene
Britt E Heidemann, Charlotte Koopal, Alexis Baass, et al.
Tropical Medicine & International Health : TM & IH
|
October 27, 2021
Hepatic steatosis is associated with anthropometry, cardio-metabolic disease risk, sex, age and urbanisation, but not with ethnicity in adult Kenyans
Sophie E Kastberg, Helene S Lund, Emanuella De Lucia-Rolfe, et al.
Journal of Clinical Lipidology
|
July 26, 2025
Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participants
Asia Sikora Kessler, T Michelle Brown, Emily Bratlee-Whitaker, et al.
The Canadian Journal of Cardiology
|
November 14, 2021
Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH Registry
Gabrielle Roy, Patrick Couture, Jacques Genest, et al.
American Journal of Preventive Cardiology
|
June 15, 2026
Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR Trials
Christie M Ballantyne, Alexis Baass, Robert S Rosenson, et al.
Atherosclerosis
|
October 2, 2018
Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registry
Liam R Brunham, Isabelle Ruel, Etienne Khoury, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Atherosclerosis
|
September 9, 2020
Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experience
Sumayah Aljenedil, Latifah Alothman, Alexandre M Bélanger, et al.
Journal of the Endocrine Society
|
January 30, 2020
Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort
Abhimanyu Garg, Sergio Fazio, P Barton Duell, et al.
The New England Journal of Medicine
|
September 3, 2024
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
Gerald F Watts, Robert S Rosenson, Robert A Hegele, et al.
The Journal of Biological Chemistry
|
December 22, 2016
The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIA
Delia Susan-Resiga, Emmanuelle Girard, Robert Scott Kiss, et al.
Clinical Genetics
|
July 5, 2022
Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene
Britt E Heidemann, Charlotte Koopal, Alexis Baass, et al.
Tropical Medicine & International Health : TM & IH
|
October 27, 2021
Hepatic steatosis is associated with anthropometry, cardio-metabolic disease risk, sex, age and urbanisation, but not with ethnicity in adult Kenyans
Sophie E Kastberg, Helene S Lund, Emanuella De Lucia-Rolfe, et al.
Journal of Clinical Lipidology
|
July 26, 2025
Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participants
Asia Sikora Kessler, T Michelle Brown, Emily Bratlee-Whitaker, et al.
The Canadian Journal of Cardiology
|
November 14, 2021
Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH Registry
Gabrielle Roy, Patrick Couture, Jacques Genest, et al.
American Journal of Preventive Cardiology
|
June 15, 2026
Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR Trials
Christie M Ballantyne, Alexis Baass, Robert S Rosenson, et al.
Atherosclerosis
|
October 2, 2018
Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registry
Liam R Brunham, Isabelle Ruel, Etienne Khoury, et al.
Page
of 10